Kezar Life SciencesAktie
 
Mehr Daten anzeigen
Kezar Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference

Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced its Chief Executive Officer, John Fowler, will present a …

Wertpapier:
Kezar Life Sciences Added to the Nasdaq Biotechnology Index

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that it has been added to the NASDAQ Biotech Index …

Wertpapier:

Nachrichten

ZeitTitel
12.11.20
Kezar Life Sciences to Present During Upcoming Virtual Investor Conferences
05.11.20
Kezar Life Sciences Reports Third-Quarter 2020 Financial Results and Provides Business Updates
05.11.20
Kezar Highlights Broad Therapeutic Potential of KZR-616 During ACR Convergence 2020
23.10.20
Kezar Life Sciences Announces Orphan Drug Designations for KZR-616 for the Treatment of Polymyositis and Dermatomyositis
15.10.20
Kezar Life Sciences to Present at Four Upcoming Virtual Medical and Scientific Conferences
17.09.20
Kezar Highlights Data from MISSION Phase 1b Study of KZR-616 during the Pan American Congress of Rheumatology
10.09.20
Kezar Life Sciences to Present at The Myositis Association International Annual Patient Conference and the Pan-American Congress of Rheumatology
05.08.20
Kezar Life Sciences Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update
03.08.20
Kezar Life Sciences to Participate in Two Upcoming Virtual Investor Conferences
29.07.20
Kezar Life Sciences to Release Second Quarter Financial Results and General Business Updates on August 5, 2020
09.06.20
Kezar Announces Pricing of a Public Offering of $46.7 million of Common Stock and Pre-Funded Warrants
08.06.20
Kezar Announces Proposed Public Offering of Common Stock
03.06.20
Kezar Provides Data Update from MISSION Study of KZR-616
28.05.20
Kezar Life Sciences to Participate in Fireside Chat During the Jefferies Virtual Healthcare Conference
20.05.20
Kezar Announces Presentations During Upcoming Scientific Conferences
Diskussionen

Kezar Life Sciences Forum

Die wichtigsten Links der Community
Börsenforum - der komplette Überblick
Alle Foren von Anfänger bis Zertifikate
Forum-Suche

Diskussionen

TitelNeuester Beitrag
Kezar Life Sciences - KZR 616
Erstellt: 10.02.20, 22:36 von pako21		04.06.20, 19:01
Was halten Sie von den neusten Entwicklungen zu Kezar Life Sciences?


Community

Meistdiskutierte Aktien (24h)

WertpapierBeiträge
DAX
170
NeutriSci International
106
Lyxor ETF MSCI World D €
97
Plug Power
93
Halo Labs
83
Sernova
73
Gold
67
BioNTech
67
Xiaomi Registered (B)
61
Tesla
60